Ignite Creation Date:
2025-12-25 @ 12:40 AM
Ignite Modification Date:
2026-02-07 @ 3:46 PM
Study NCT ID:
NCT04345367
Status:
COMPLETED
Last Update Posted:
2022-07-08
First Post:
2020-03-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
Sponsor:
Pfizer
Organization: